| 前收盘价格 | 26.37 |
| 收盘价格 | 26.49 |
| 成交量 | 380,270 |
| 平均成交量 (3个月) | 390,739 |
| 市值 | 1,062,689,600 |
| 价格/销量 (P/S) | 8.67 |
| 股市价格/股市净资产 (P/B) | 7.07 |
| 52周波幅 | |
| 利润日期 | 3 Nov 2026 |
| 营业毛利率 | -62.50% |
| 营业利益率 (TTM) | -69.33% |
| 稀释每股收益 (EPS TTM) | -1.25 |
| 季度收入增长率 (YOY) | 42.30% |
| 总债务/股东权益 (D/E MRQ) | 12.03% |
| 流动比率 (MRQ) | 17.36 |
| 营业现金流 (OCF TTM) | -36.90 M |
| 杠杆自由现金流 (LFCF TTM) | -26.02 M |
| 资产报酬率 (ROA TTM) | -17.46% |
| 股东权益报酬率 (ROE TTM) | -41.39% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Devices (US) | 混合的 | 混合的 |
| Medical Devices (全球的) | 混合的 | 混合的 | |
| 股票 | CeriBell, Inc. | 混合的 | 看跌 |
AIStockmoo 评分
| 分析师共识 | NA |
| 内部交易活动 | -3.0 |
| 价格波动 | -4.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | 2.0 |
| 相对估值 | NA |
| 财务健康 | NA |
| AI Insight | NA |
| 平均 | -1.25 |
|
CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable, and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its products are Point-of-Care EEG, Clarity, and EEG Portal. |
|
| 部门 | Healthcare |
| 行业 | Medical Devices |
| 投资方式 | Small Growth |
| 内部持股比例 | 10.54% |
| 机构持股比例 | 84.45% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Red Tree Management, Llc | 30 Jun 2026 | 2,205,661 |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合